In addition, SDHB mutation carriers have been associated with an increased risk of developing other neoplasms, including renal cell carcinoma, gastrointestinal stromal tumors (GISTs) and papillary thyroid cancer [9]. This evidence concerns the gene SDHB and hereditary clear cell renal cell carcinoma.